Eclipse
ClinicalTrials.gov NCT03108456
Research payments
$17,719,160
Through program year 2025, $17,719,160 in research payments was reported against Eclipse, across 3,507 payments.
- Paid by (largest first)
- Cardiovascular Systems Inc.; Abbott Laboratories
- ClinicalTrials.gov
- NCT03108456
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $954,002 | 154 |
| 2023 | Research | $1,109,870 | 194 |
| 2022 | Research | $2,967,649 | 629 |
| 2021 | Research | $3,706,711 | 742 |
| 2020 | Research | $3,878,953 | 711 |
| 2019 | Research | $5,101,974 | 1,077 |
Breakdown
Usually the institution or organisation running the study, not a person.
Only reported on some payments, and a payment can report more than one category, so these amounts overlap.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Nicholas Hanna Tulsa, OK Named on 114 payments
- Suhail Allaqaband Milwaukee, WI Named on 79 payments
- Ivan Chavez Minneapolis, MN Named on 70 payments
- Apurva Badheka Everett, WA Named on 64 payments
- Kendrick Shunk San Francisco, CA Named on 64 payments
- Jithendra Choudary Richmond, IN Named on 61 payments
- Richard Shlofmitz Roslyn, NY Named on 60 payments
- Gautam Kumar Atlanta, GA Named on 57 payments
- Andres Pineda Maldonado Whiteville, NC Named on 57 payments
- Nikolaos Kakouros Worcester, MA Named on 56 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.